# Colchicine Versus Placebo in Acute Myocarditis Patients

Study · id `cardio:ct-nct05855746` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05855746](<https://clinicaltrials.gov/study/NCT05855746>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05855746

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT05855746. Randomized; quadruple masking; primary purpose treatment. Start 2024-07-16 (actual); primary completion 2028-01-16 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT05855746, source copy `cardio:ctgov-nct05855746-2026-02-25`, retrieved 2026-10-31)
- Started: 2024-07-16 (actual) (ClinicalTrials.gov record NCT05855746, source copy `cardio:ctgov-nct05855746-2026-02-25`, retrieved 2026-10-31)
- Primary completion: 2028-01-16 (anticipated) (ClinicalTrials.gov record NCT05855746, source copy `cardio:ctgov-nct05855746-2026-02-25`, retrieved 2026-10-31)
- Completion: 2028-07-16 (anticipated) (ClinicalTrials.gov record NCT05855746, source copy `cardio:ctgov-nct05855746-2026-02-25`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT05855746, source copy `cardio:ctgov-nct05855746-2026-02-25`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05855746-2026-02-25`, retrieved 2026-10-31)

## The registry's words

- Brief title: Colchicine Versus Placebo in Acute Myocarditis Patients
- Acronym: ARGO
- Condition: Acute Myocarditis
- Intervention (Drug): Colchicine Pill
- Intervention (Drug): Placebo
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER
- Collaborator: Hospices Civils de Lyon
- Collaborator class: OTHER
- Collaborator: Fonds de Dotation ACTION
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)
- Registry lists this organization as a collaborator: Hospices Civils de Lyon (`cardio:org-hospices-civils-de-lyon`)
- Registry lists this organization as a collaborator: Fonds de Dotation ACTION (`cardio:org-fonds-de-dotation-action`)

## Provenance

Content hash: 54f011d39cc4f8d2b8930ecab9a5df093ccf8080e5c6dd9676ccf4cda4317ebf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
